Charles Williams
Director of Finance/CFO chez SURROZEN, INC.
Fortune : 23 157 $ au 31/03/2024
Postes actifs de Charles Williams
Sociétés | Poste | Début | Fin |
---|---|---|---|
SURROZEN, INC. | Chief Operating Officer | 01/02/2024 | - |
Director of Finance/CFO | 01/11/2020 | - |
Historique de carrière de Charles Williams
Anciens postes connus de Charles Williams
Sociétés | Poste | Début | Fin |
---|---|---|---|
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/01/2013 | 01/11/2020 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
Formation de Charles Williams
Cornell University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Irlande | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
SURROZEN, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
- Bourse
- Insiders
- Charles Williams
- Expérience